Evidence map›Paper›PMID 22762544›Full record

ArticleApplied health economics and health policy2012

Estimating incremental costs with skew: a cautionary note.

Linnea A Polgreen, John M Brooks

Abstract read
In one paragraph

Article in Applied health economics and health policy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Economic burden due to COVID-19 in a Colombian Caribbean state, 2020 and 2021.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2024
    Article
  7. Article
  8. Observational
  9. Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Linnea A PolgreenCollege of Pharmacy, University of Iowa, Iowa City, IA 52246, USA. linnea-polgreen@uiowa.edu
John M Brooks

Funding

Comparative Effectiveness of Treatment Combinations Post MI in the ElderlyR01HS018381 · AHRQ · UNIVERSITY OF IOWA · PI SCHROEDER, MARY C. · 2010 to 2013
$1.6M
Interpreting IV Estimates with Treatment Effect Heterogeneity: ACE/ARBs & RaceRC4AG038635 · NIA · UNIVERSITY OF IOWA · PI BROOKS, JOHN M · 2010 to 2010
$1.5M
Advancing Quality Care Through Translation ResearchR13HS014141 · AHRQ · UNIVERSITY OF IOWA · PI TITLER, MARITA G · 2003 to 2003
–
AHRQ HHS R01 HS018381AHRQ HHS R13 HS014141NIA NIH HHS RC4 AG038635
6 · The paper itself

Abstract

backgroundCost data in healthcare are often skewed across patients. Thus, researchers have used either a log transformation of the dependent variable or generalized linear models with log links. However, frequently these non-linear approaches produce non-linear incremental effects: the incremental effects differ at different levels of the covariates, and this can cause dramatic effects on predicted cost.

objectivesThe aim of this study was to demonstrate that when modelling skewed data, log link functions or log transformations are not necessary and have unintended effects.

methodsWe simulated cost data using a linear model with a 'treatment', a covariate and a specified number of observations with excessive cost (skewed data). We also used actual data from a pain-relief intervention among hip-replacement patients. We then estimated cost models using various functional approaches suggested to handle skew and calculated the incremental cost of treatment at various levels of the covariate(s).

resultsAll of these methods provide unbiased estimates of the incremental effect of treatment on costs at the mean level of the covariate. However, in some log-based models the implied incremental treatment cost doubled between extreme low and high values of the covariate in a manner inconsistent with the underlying linear model.

conclusionsAlthough specification checks are always needed, the potential for misleading incremental estimates resulting from log-based specifications is often ignored. In this era of cost containment and comparisons of treatment effectiveness it is vital that researchers and policymakers understand the limitation of the inferences that can be made using log-based models for patients whose characteristics differ from the sample mean.

Indexed as

BiasComputer SimulationData Interpretation, StatisticalEvidence-Based MedicineHealth Care CostsHip FracturesHumansLinear ModelsNormal DistributionPain ManagementRandomized Controlled Trials as Topic

Identifiers

PMID22762544
PMCPMC4745583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.